Riboflavin to treat nucleoside analogue-induced lactic acidosis

Lancet

Volumn 352, Issue 9124, 1998, Pages 291-292

  Fouty, Brian ^a   Frerman, Frank ^b   Reves, Randall ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; RIBOFLAVIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; FATTY LIVER; FEMALE; HUMAN; LACTIC ACIDOSIS; PRIORITY JOURNAL; RIBOFLAVIN DEFICIENCY;

EID: 0032566235     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60266-8     Document Type: Article

References (5)

1. 1 Freiman J, Helfert K, Hamrell M, Stein D. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 1993; 7: 379-85.
2. 2 Bissuel F, Bruneel F, Habersetzer F, et al. Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Int Med 1994; 235: 367-72.
3. 3 Zaman Z, Verwilghen R. Effects of riboflavin deficiency in oxidative phosphorylation, flavin enzymes, and coenzymes in rat liver. Biochem Biophys Res Comm 1975; 67: 1192-98.
4. 4 Beach R, Mantero-Atienza E, Shor-Posner G, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992; 6: 701-08.
5. 5 Pinto J, Huang Y, Rivlin R. Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramide, and amitriptyline. J Clin Invest 1981; 67: 1500-06.